An increasing amount of evidence has now indicated that the altered expression of RECK is involved in numerous solid tumors, including lung cancer, human breast carcinoma, pancreatic cancer, non-small cell lung cancer and colorectal cancer (10–12). This evidence concerns the gene RECK and pancreatic neoplasm.